PBM SCHEDULE 13D/A: SEC filing

Psyence Labs Ltd.

Filed with the SEC on · accession 0001213900-26-109613

PBM filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Oct 15, 2026. Psyence Labs Ltd. filed an amendment to its Schedule 13D disclosing the names and positions of its directors and executive officers, including CEO Tony Budden. The stock moved +4.6% by the first close after the filing.

Summary of the filing

Psyence Labs Ltd. filed an amendment to its Schedule 13D disclosing the names and positions of its directors and executive officers, including CEO Tony Budden. This is a routine administrative update to the beneficial ownership disclosure.

Key details

Reporting person / subject of schedule 13dPsyence Labs Ltd.
Director of psyence labs ltd.Control Services Corp.
IssuerPsyence Biomedical Ltd.
Chief executive officer of psyence labs ltd.Tony Budden
Authorized signatory of control services corp.Ronel Anneli Williams
Authorized signatory of control services corp.Kim Setzkorn

How PBM stock reacted

Close before

$4.13

Oct 14, 2026

First close after

+4.60%

$4.32

5 trading days

+9.44%

$4.52

Since filing

-20.34%

$3.29

✦ Ask GOAX AI about this filing — what it means for PBM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PBM?

Click here

Frequently asked questions

What did PBM file with the SEC on Oct 15, 2026?

PBM filed a SCHEDULE 13D/A (SEC filing). Psyence Labs Ltd. filed an amendment to its Schedule 13D disclosing the names and positions of its directors and executive officers, including CEO Tony Budden. This is a routine administrative update to the beneficial ownership disclosure.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

How did PBM stock react to this filing?

PBM closed at $4.13 before the filing and $4.32 on Oct 15, 2026 (+4.60%). Five trading days later: $4.52 (+9.44%).

Other PBM SEC filings

Get alerts when PBM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days